Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Cumberland Pharmaceuticals (CPIX) EPS (Basic) (2016 - 2025)

Historic EPS (Basic) for Cumberland Pharmaceuticals (CPIX) over the last 17 years, with Q3 2025 value amounting to -$0.13.

  • Cumberland Pharmaceuticals' EPS (Basic) fell 1818.18% to -$0.13 in Q3 2025 from the same period last year, while for Sep 2025 it was -$0.24, marking a year-over-year increase of 6883.12%. This contributed to the annual value of -$0.46 for FY2024, which is 415.74% down from last year.
  • As of Q3 2025, Cumberland Pharmaceuticals' EPS (Basic) stood at -$0.13, which was down 1818.18% from -$0.05 recorded in Q2 2025.
  • In the past 5 years, Cumberland Pharmaceuticals' EPS (Basic) ranged from a high of $0.08 in Q2 2021 and a low of -$0.44 during Q4 2023
  • Moreover, its 5-year median value for EPS (Basic) was -$0.09 (2022), whereas its average is -$0.09.
  • Per our database at Business Quant, Cumberland Pharmaceuticals' EPS (Basic) skyrocketed by 17272.73% in 2021 and then tumbled by 126684.18% in 2024.
  • Quarter analysis of 5 years shows Cumberland Pharmaceuticals' EPS (Basic) stood at -$0.29 in 2021, then skyrocketed by 41.38% to -$0.17 in 2022, then crashed by 159.26% to -$0.44 in 2023, then skyrocketed by 69.31% to -$0.14 in 2024, then grew by 3.88% to -$0.13 in 2025.
  • Its EPS (Basic) stands at -$0.13 for Q3 2025, versus -$0.05 for Q2 2025 and $0.08 for Q1 2025.